Cargando…

Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice

BACKGROUND: Lack of suitable mouse models has hindered the studying of diabetic macrovascular complications. We examined the effects of type 2 diabetes on coronary artery disease and cardiac function in hypercholesterolemic low-density lipoprotein receptor-deficient apolipoprotein B100-only mice (LD...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinonen, Suvi E, Merentie, Mari, Hedman, Marja, Mäkinen, Petri I, Loponen, Elina, Kholová, Ivana, Bosch, Fatima, Laakso, Markku, Ylä-Herttuala, Seppo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141395/
https://www.ncbi.nlm.nih.gov/pubmed/21718508
http://dx.doi.org/10.1186/1475-2840-10-59
_version_ 1782208671006064640
author Heinonen, Suvi E
Merentie, Mari
Hedman, Marja
Mäkinen, Petri I
Loponen, Elina
Kholová, Ivana
Bosch, Fatima
Laakso, Markku
Ylä-Herttuala, Seppo
author_facet Heinonen, Suvi E
Merentie, Mari
Hedman, Marja
Mäkinen, Petri I
Loponen, Elina
Kholová, Ivana
Bosch, Fatima
Laakso, Markku
Ylä-Herttuala, Seppo
author_sort Heinonen, Suvi E
collection PubMed
description BACKGROUND: Lack of suitable mouse models has hindered the studying of diabetic macrovascular complications. We examined the effects of type 2 diabetes on coronary artery disease and cardiac function in hypercholesterolemic low-density lipoprotein receptor-deficient apolipoprotein B100-only mice (LDLR(-/-)ApoB(100/100)). METHODS AND RESULTS: 18-month-old LDLR(-/-)ApoB(100/100 )(n = 12), diabetic LDLR(-/-)ApoB(100/100 )mice overexpressing insulin-like growth factor-II (IGF-II) in pancreatic beta cells (IGF-II/LDLR(-/-)ApoB(100/100), n = 14) and age-matched C57Bl/6 mice (n = 15) were studied after three months of high-fat Western diet. Compared to LDLR(-/-)ApoB(100/100 )mice, diabetic IGF-II/LDLR(-/-)ApoB(100/100 )mice demonstrated more calcified atherosclerotic lesions in aorta. However, compensatory vascular enlargement was similar in both diabetic and non-diabetic mice with equal atherosclerosis (cross-sectional lesion area ~60%) and consequently the lumen area was preserved. In coronary arteries, both hypercholesterolemic models showed significant stenosis (~80%) despite positive remodeling. Echocardiography revealed severe left ventricular systolic dysfunction and anteroapical akinesia in both LDLR(-/-)ApoB(100/100 )and IGF-II/LDLR(-/-)ApoB(100/100 )mice. Myocardial scarring was not detected, cardiac reserve after dobutamine challenge was preserved and ultrasructural changes revealed ischemic yet viable myocardium, which together with coronary artery stenosis and slightly impaired myocardial perfusion suggest myocardial hibernation resulting from chronic hypoperfusion. CONCLUSIONS: LDLR(-/-)ApoB(100/100 )mice develop significant coronary atherosclerosis, severe left ventricular dysfunction with preserved but diminished cardiac reserve and signs of chronic myocardial hibernation. However, the cardiac outcome is not worsened by type 2 diabetes, despite more advanced aortic atherosclerosis in diabetic animals.
format Online
Article
Text
id pubmed-3141395
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31413952011-07-23 Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice Heinonen, Suvi E Merentie, Mari Hedman, Marja Mäkinen, Petri I Loponen, Elina Kholová, Ivana Bosch, Fatima Laakso, Markku Ylä-Herttuala, Seppo Cardiovasc Diabetol Original Investigation BACKGROUND: Lack of suitable mouse models has hindered the studying of diabetic macrovascular complications. We examined the effects of type 2 diabetes on coronary artery disease and cardiac function in hypercholesterolemic low-density lipoprotein receptor-deficient apolipoprotein B100-only mice (LDLR(-/-)ApoB(100/100)). METHODS AND RESULTS: 18-month-old LDLR(-/-)ApoB(100/100 )(n = 12), diabetic LDLR(-/-)ApoB(100/100 )mice overexpressing insulin-like growth factor-II (IGF-II) in pancreatic beta cells (IGF-II/LDLR(-/-)ApoB(100/100), n = 14) and age-matched C57Bl/6 mice (n = 15) were studied after three months of high-fat Western diet. Compared to LDLR(-/-)ApoB(100/100 )mice, diabetic IGF-II/LDLR(-/-)ApoB(100/100 )mice demonstrated more calcified atherosclerotic lesions in aorta. However, compensatory vascular enlargement was similar in both diabetic and non-diabetic mice with equal atherosclerosis (cross-sectional lesion area ~60%) and consequently the lumen area was preserved. In coronary arteries, both hypercholesterolemic models showed significant stenosis (~80%) despite positive remodeling. Echocardiography revealed severe left ventricular systolic dysfunction and anteroapical akinesia in both LDLR(-/-)ApoB(100/100 )and IGF-II/LDLR(-/-)ApoB(100/100 )mice. Myocardial scarring was not detected, cardiac reserve after dobutamine challenge was preserved and ultrasructural changes revealed ischemic yet viable myocardium, which together with coronary artery stenosis and slightly impaired myocardial perfusion suggest myocardial hibernation resulting from chronic hypoperfusion. CONCLUSIONS: LDLR(-/-)ApoB(100/100 )mice develop significant coronary atherosclerosis, severe left ventricular dysfunction with preserved but diminished cardiac reserve and signs of chronic myocardial hibernation. However, the cardiac outcome is not worsened by type 2 diabetes, despite more advanced aortic atherosclerosis in diabetic animals. BioMed Central 2011-06-30 /pmc/articles/PMC3141395/ /pubmed/21718508 http://dx.doi.org/10.1186/1475-2840-10-59 Text en Copyright ©2011 Heinonen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Heinonen, Suvi E
Merentie, Mari
Hedman, Marja
Mäkinen, Petri I
Loponen, Elina
Kholová, Ivana
Bosch, Fatima
Laakso, Markku
Ylä-Herttuala, Seppo
Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
title Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
title_full Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
title_fullStr Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
title_full_unstemmed Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
title_short Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
title_sort left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic ldl-receptor deficient apolipoprotein b100-only mice
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141395/
https://www.ncbi.nlm.nih.gov/pubmed/21718508
http://dx.doi.org/10.1186/1475-2840-10-59
work_keys_str_mv AT heinonensuvie leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT merentiemari leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT hedmanmarja leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT makinenpetrii leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT loponenelina leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT kholovaivana leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT boschfatima leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT laaksomarkku leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice
AT ylaherttualaseppo leftventriculardysfunctionwithreducedfunctionalcardiacreserveindiabeticandnondiabeticldlreceptordeficientapolipoproteinb100onlymice